BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

LCA-Vision Reports First Quarter 2013 Procedure Volume


4/2/2013 9:29:40 AM

CINCINNATI, April 2, 2013 /PRNewswire/ -- LCA-Vision Inc. (NASDAQ: LCAV), a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 16,272 procedures were performed during the first quarter of 2013, compared with 20,987 procedures performed during the first quarter of 2012.

"We faced a difficult comparison with the first quarter of 2012 where year-over-year procedure volume increased 11%. We also believe that the lowering of the maximum contribution for flexible spending accounts to $2,500 from $5,000, which took effect at the beginning of this year as mandated under the federal Patient Protection & Affordable Care Act, had a negative impact. Results from a recently conducted company-sponsored survey showed that lower contribution amounts to flexible spending accounts and health savings accounts put approximately 10% of prospective LasikPlus® patients at risk for not moving forward with the procedure," said LCA-Vision Chief Executive Officer Michael J. Celebrezze. "We started the first quarter with a significant deficit in patient bookings compared with the prior year; however, we gained some ground in bookings and procedures as the quarter progressed, which we attribute primarily to improvements in our direct-to-consumer advertising."

LCA-Vision will release first quarter 2013 financial results prior to the market open on Tuesday, April 30, 2013 with a conference call and webcast to follow at 10:00 a.m. Eastern time.

To access the conference call, dial 866-322-1352 (within the United States and Canada) or 706-643-6246 (international callers). The webcast will be available at the investor relations section of LCA-Vision's website. A replay of the call and webcast will begin approximately two hours after the live call has ended. To access the replay, dial 855-859-2056 (within the United States and Canada) or 404-537-3406 (international callers) and enter the conference ID number: 28928042.

About LCA-Vision Inc./LasikPlus®
LCA-Vision Inc., a leading provider of laser vision correction services, owns and operates 54 LasikPlus® vision centers in the United States: 49 full-service LasikPlus® fixed-site laser vision correction centers and five pre- and post-operative LasikPlus® satellite centers.



For Additional Information




Company Contact:

Investor Relations Contact:

Barb Kise, LCA-Vision

Jody Cain, LHA

513-792-9292

310-691-7100


@LHA_IR_PR



SOURCE LCA-Vision Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES